Office of the Commissioner of Lobbying of Canada
Registry of Lobbyists

Monthly Communication Report

15599-654171

Corporation: Novartis Pharmaceuticals Canada Inc.
Associated registration: 957165-15599-39
Communication date: 2025-10-09
Posted date: 2025-11-15

Designated Public Office Holders who participated in the communication: Karim Bardeesy, Member of Parliament
House of Commons
 
List of Details
Subject matter Detail
Health, Industry Science and Technology Strategy, advocating for the development of a Biopharma sector in support of more research & development in Canada.
 
Responsible Officer who filed this communication report: Mark Vineis
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: